Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker JAZZ
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | Sale | 5,923 | $237.39 | $1.4M Sale | Form 4 ↗ |
| Nov 6, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | Sale | 24,483 | $236.84 | $5.8M Sale | Form 4 ↗ |
| Nov 6, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | Sale | 10,688 | $235.82 | $2.5M Sale | Form 4 ↗ |
| Nov 6, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | Sale | 27,714 | $234.91 | $6.5M Sale | Form 4 ↗ |
| Nov 4, 2026 | Patricia Carr SVP, Chief Accounting Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 163 | $231.27 | $37.7K Sale | Form 4 ↗ |
| Nov 4, 2026 | Patricia Carr SVP, Chief Accounting Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 1,250 | $231.37 | $289.2K Sale | Form 4 ↗ |
| Nov 3, 2026 | Renee D. Gala President & CEO, Director | JAZZ Jazz Pharmaceuticals plc | Sale | 1,000 | $225.37 | $225.4K Sale | Form 4 ↗ |
| Nov 2, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | Sale | 6,000 | $215.84 | $1.3M Sale | Form 4 ↗ |
| Sep 10, 2026 | Neena M. Patil EVP & Chief Legal Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 1,200 | $240.94 | $289.1K Sale | Form 4 ↗ |
| Sep 8, 2026 | Renee D. Gala President & CEO | JAZZ Jazz Pharmaceuticals plc | Sale | 2,000 | $243.03 | $486.1K Sale | Form 4 ↗ |
| Sep 1, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | Sale | 6,000 | $250.13 | $1.5M Sale | Form 4 ↗ |
| Aug 27, 2026 | Robert Iannone EVP, Global Head of R&D & CMO | JAZZ Jazz Pharmaceuticals plc | Sale | 300 | $252.76 | $75.8K Sale | Form 4 ↗ |
| Aug 27, 2026 | Robert Iannone EVP, Global Head of R&D & CMO | JAZZ Jazz Pharmaceuticals plc | Sale | 9,259 | $251.95 | $2.3M Sale | Form 4 ↗ |
| Aug 27, 2026 | Robert Iannone EVP, Global Head of R&D & CMO | JAZZ Jazz Pharmaceuticals plc | Sale | 19,639 | $250.60 | $4.9M Sale | Form 4 ↗ |
| Aug 27, 2026 | Robert Iannone EVP, Global Head of R&D & CMO | JAZZ Jazz Pharmaceuticals plc | Sale | 18,113 | $250.02 | $4.5M Sale | Form 4 ↗ |
| Aug 27, 2026 | Robert Iannone EVP, Global Head of R&D & CMO | JAZZ Jazz Pharmaceuticals plc | Sale | 11,423 | $248.67 | $2.8M Sale | Form 4 ↗ |
| Aug 27, 2026 | Robert Iannone EVP, Global Head of R&D & CMO | JAZZ Jazz Pharmaceuticals plc | Sale | 18,187 | $247.86 | $4.5M Sale | Form 4 ↗ |
| Aug 3, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | Sale | 6,000 | $252.98 | $1.5M Sale | Form 4 ↗ |
| Jul 1, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | Sale | 6,000 | $240.47 | $1.4M Sale | Form 4 ↗ |
| Jun 15, 2026 | Mark Douglas Smith Director | JAZZ Jazz Pharmaceuticals plc | Sale | 1,157 | $230.55 | $266.7K Sale | Form 4 ↗ |
| Jun 10, 2026 | Neena M. Patil EVP & Chief Legal Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 1,200 | $231.83 | $278.2K Sale | Form 4 ↗ |
| Jun 1, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | Sale | 6,000 | $235.12 | $1.4M Sale | Form 4 ↗ |
| May 28, 2026 | Samantha Pearce EVP, Chief Commercial Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 6,907 | $235.41 | $1.6M Sale | Form 4 ↗ |
| May 28, 2026 | Neena M. Patil EVP & Chief Legal Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 1,192 | $236.97 | $282.5K Sale | Form 4 ↗ |
| May 22, 2026 | Heather Ann McSharry Director | JAZZ Jazz Pharmaceuticals plc | Sale | 2,000 | $241.00 | $482.0K Sale | Form 4 ↗ |
| May 22, 2026 | Rick E. Winningham Director | JAZZ Jazz Pharmaceuticals plc | Sale | 2,741 | $241.57 | $662.1K Sale | Form 4 ↗ |
| May 1, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | Sale | 6,000 | $203.33 | $1.2M Sale | Form 4 ↗ |
| Apr 1, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | Sale | 24 | $191.74 | $4,602 Sale | Form 4 ↗ |
| Apr 1, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | Sale | 2,292 | $190.94 | $437.6K Sale | Form 4 ↗ |
| Apr 1, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | Sale | 3,684 | $190.22 | $700.8K Sale | Form 4 ↗ |
| Mar 9, 2026 | Patricia Carr SVP, Chief Accounting Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 1,287 | $182.94 | $235.4K Sale | Form 4 ↗ |
| Mar 3, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | Sale | 233 | $187.84 | $43.8K Sale | Form 4 ↗ |
| Mar 3, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | Sale | 2,608 | $186.73 | $487.0K Sale | Form 4 ↗ |
| Mar 3, 2026 | Bruce C. Cozadd Director | JAZZ Jazz Pharmaceuticals plc | Sale | 3,159 | $186.09 | $587.9K Sale | Form 4 ↗ |
| Feb 27, 2026 | Patricia Carr SVP, Chief Accounting Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 1,117 | $190.91 | $213.2K Sale | Form 4 ↗ |
| Feb 27, 2026 | Norbert G. Riedel Director | JAZZ Jazz Pharmaceuticals plc | Sale | 3,415 | $192.00 | $655.7K Sale | Form 4 ↗ |
| Feb 26, 2026 | Mary Elizabeth Henderson SVP, Technical Operations | JAZZ Jazz Pharmaceuticals plc | Sale | 5,343 | $194.49 | $1.0M Sale | Form 4 ↗ |
| Feb 26, 2026 | Patricia Carr SVP, Chief Accounting Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 1,253 | $194.11 | $243.2K Sale | Form 4 ↗ |
| Feb 26, 2026 | Neena M. Patil EVP & Chief Legal Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 197 | $193.60 | $38.1K Sale | Form 4 ↗ |
| Feb 26, 2026 | Neena M. Patil EVP & Chief Legal Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 1,009 | $192.79 | $194.5K Sale | Form 4 ↗ |
| Feb 26, 2026 | Neena M. Patil EVP & Chief Legal Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 1,784 | $191.88 | $342.3K Sale | Form 4 ↗ |
| Feb 26, 2026 | Neena M. Patil EVP & Chief Legal Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 549 | $190.80 | $104.7K Sale | Form 4 ↗ |
| Feb 26, 2026 | Neena M. Patil EVP & Chief Legal Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 1,061 | $190.00 | $201.6K Sale | Form 4 ↗ |
| Feb 26, 2026 | Neena M. Patil EVP & Chief Legal Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 3,523 | $193.58 | $682.0K Sale | Form 4 ↗ |
| Feb 26, 2026 | Neena M. Patil EVP & Chief Legal Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 11,529 | $191.65 | $2.2M Sale | Form 4 ↗ |
| Feb 26, 2026 | Neena M. Patil EVP & Chief Legal Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 2,916 | $189.81 | $553.5K Sale | Form 4 ↗ |
| Feb 26, 2026 | Neena M. Patil EVP & Chief Legal Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 15,555 | $190.28 | $3.0M Sale | Form 4 ↗ |
| Feb 26, 2026 | Neena M. Patil EVP & Chief Legal Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 875 | $192.07 | $168.1K Sale | Form 4 ↗ |
| Feb 26, 2026 | Neena M. Patil EVP & Chief Legal Officer | JAZZ Jazz Pharmaceuticals plc | Sale | 16,602 | $192.53 | $3.2M Sale | Form 4 ↗ |
| Dec 9, 2025 | Mary Elizabeth Henderson SVP, Technical Operations | JAZZ Jazz Pharmaceuticals plc | Sale | 2,238 | $169.51 | $379.4K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 9:21 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances